Allopurinol Therapy Guidelines

Initial Dosing Strategy

The American College of Rheumatology recommends starting with a low dose of allopurinol (≤100 mg/day for normal renal function, ≤50 mg/day in patients with CKD) to reduce the risk of allopurinol hypersensitivity syndrome and acute flares 1, 2
Increase dose by 100 mg increments every 2-4 weeks until reaching the serum urate target of <6 mg/dL (360 μmol/L), with doses above 300 mg/day often necessary to achieve target urate levels 3
For patients with severe gout, consider a lower target of <5 mg/dL (300 μmol/L) until crystal dissolution is complete 3

Always initiate concomitant anti-inflammatory prophylaxis when starting allopurinol to prevent acute gout flares, with recommended options including colchicine 0.5-1 mg/day, NSAIDs at low dose, or low-dose prednisone/prednisolone 1, 2, 3, 5, 6
Continue prophylaxis for 3-6 months after initiating allopurinol, with ongoing evaluation and extended prophylaxis if flares persist 1, 2, 6

Allopurinol is strongly recommended as first-line urate-lowering therapy for all patients with gout, including those with moderate-to-severe CKD (stage ≥3) 1, 2, 5
Monitor serum uric acid levels regularly to guide dose titration until target is reached, and check renal function before starting and periodically during treatment 3, 4

Emphasize that allopurinol is lifelong therapy; discontinuation leads to recurrence of gout flares in approximately 87% of patients within 5 years 4